Company intelligence / Profile preview
EXO Biologics
Liège, Belgiumexobio.be ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
EXO Biologics develops biopharmaceuticals based on extracellular vesicles/exosomes, focusing on rare diseases with high unmet medical needs. Their lead program uses allogeneic umbilical cord mesenchymal cells-derived EVs for bronchopulmonary dysplasia, currently in Phase 2. They also have a preclinical program targeting inflammatory bowel disease. The company has developed a GMP-compliant manufacturing platform and offers R&D-grade as well as clinical-grade exosome production services through its "ExoXpert" division. They are active participants in collaborative projects to advance the industrialization of exosome therapeutics.
- Therapeutic areas
- PulmonologyImmunologyGastroenterology
- Modalities
- Exosomes / Extracellular Vesicles (EVs)Mesenchymal stem cell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Collaborates with researchers, pharmaceutical companies, and stakeholders globallyCentral role in the BioWin “ExoFasttrack” project to build an industrial ecosystem for exosome therapeutics
Beyond the preview
Go deeper on EXO Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EXO Biologics.